Your browser doesn't support javascript.
loading
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose.
Gibson, C Michael; Mack, Michael J; Lee, Victoria T; Schneider, David J; Sellke, Frank W; Ohman, E Magnus; Thourani, Vinod H; Doros, Gheorghe; Kroger, Hans; Cutlip, Donald E; Deliargyris, Efthymios N.
Afiliación
  • Gibson CM; The Baim Institute and Harvard Medical School, Boston, MA. Electronic address: charlesmichaelgibson@gmail.com.
  • Mack MJ; Baylor Scott & White Health, Baylor Scott & White Research Institute, Dallas, TX.
  • Lee VT; CytoSorbents Inc, Princeton, NJ.
  • Schneider DJ; Department of Medicine and Cardiovascular Research Institute, University of Vermont, Burlington, VT.
  • Sellke FW; Division of Cardiothoracic Surgery, Alpert Medical School of Brown University, Providence, RI.
  • Ohman EM; Duke Clinical Research Institute, Duke Program for Advanced Coronary Disease, Duke University Medical Center, Durham, NC.
  • Thourani VH; Department of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, GA.
  • Doros G; The Baim Institute and Harvard Medical School, Boston, MA; Boston University School of Public Health, Boston, MA.
  • Kroger H; CytoSorbents Inc, Princeton, NJ.
  • Cutlip DE; The Baim Institute and Harvard Medical School, Boston, MA.
  • Deliargyris EN; CytoSorbents Inc, Princeton, NJ.
Am Heart J ; 245: 19-28, 2022 03.
Article en En | MEDLINE | ID: mdl-34736855

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aspirina / Fibrinolíticos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aspirina / Fibrinolíticos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos